SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-24-011460
Filing Date
2024-03-15
Accepted
2024-03-15 16:09:01
Documents
67
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K frtx-20231231.htm   iXBRL 10-K 1316088
2 EX-21.1 a2023123110kex211.htm EX-21.1 4448
3 EX-31.1 a2023123110kex311.htm EX-31.1 10086
4 EX-32.1 a2023123110kex321.htm EX-32.1 8200
10 frtx-20231231_g1.jpg GRAPHIC 256028
  Complete submission text file 0001628280-24-011460.txt   6531840

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20231231.xsd EX-101.SCH 44908
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT frtx-20231231_cal.xml EX-101.CAL 41857
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT frtx-20231231_def.xml EX-101.DEF 212720
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20231231_lab.xml EX-101.LAB 568678
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20231231_pre.xml EX-101.PRE 386439
69 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20231231_htm.xml XML 656362
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21088 | Film No.: 24754802
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)